Ms Celine Fitzgerald:

The introduction of a tracking system was part of the Dr. Scally recommendations and we have been looking at the best way to do that. As a first step, we have agreed with the procurement team in the HSE to issue a request for information, RFI, and to allow all relevant suppliers to come back to us with details of the system that they supply. That will allow us to assess the compatibility of those systems with our systems because it is not a simple matter of buying a system. It is critical that it can be fully integrated and that we can track the samples from when they are taken by the smear taker to the conclusion. That would have to be closely integrated with our existing systems to avoid any further potential confusion or breakdowns. It is under way and it is an important feature that would be welcomed by women and users because it would be a further assurance around the process.